Clinical trials
Phase 1/2 Colonic Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Esperas Pharma Inc. | 1 |
| GlaxoSmithKline | 1 |
| Intensity Therapeutics, Inc. | 1 |
| Jennerex Biotherapeutics | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| MedImmune LLC | 1 |
| Turning Point Therapeutics, Inc. | 1 |
| University of British Columbia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 10 |
| Neoplasms | 6 |
| Breast Neoplasms | 4 |
| Colorectal Neoplasms | 4 |
| Head and Neck Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Rectal Neoplasms | 4 |
| Sarcoma | 4 |
| Bronchial Neoplasms | 3 |
| Carcinoma, Bronchogenic | 3 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.